Soliqua 100 units/mL insulin glargine and 33 mcg/mL lixisenatide prefilled pen Images

Generic Name: insulin glargine/lixisenatide

This medication has been identified as Soliqua 100 units/mL insulin glargine and 33 mcg/mL lixisenatide prefilled pen. It is supplied by Sanofi.

Soliqua is used in the treatment of Type 2 Diabetes and belongs to the drug class antidiabetic combinations. Soliqua 100 units/mL insulin glargine and 33 mcg/mL lixisenatide prefilled pen is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Soliqua

Generic Name

insulin glargine/lixisenatide

Strength

100 units/mL insulin glargine and 33 mcg/mL lixisenatide prefilled pen

Availability

Prescription only

Drug Class

Antidiabetic combinations

CSA Schedule

Not a controlled drug

Labeler / Supplier

Sanofi

National Drug Code (NDC)

00024-5761

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer